Opening the Blood-Brain Barrier with MR Imaging-guided Focused Ultrasound: Preclinical Testing on a Trans-Human Skull Porcine Model.
Opening the Blood-Brain Barrier with MR Imaging-guided Focused Ultrasound: Preclinical Testing on a Trans-Human Skull Porcine Model.
复制标题
DOI:
10.1148/radiol.2016152154
复制
发表时间:
2017-01
期刊:
影响因子:
19.7
通讯作者:
Hynynen K
中科院分区:
文献类型:
--
作者:
Huang Y;Alkins R;Schwartz ML;Hynynen K
To develop and test a protocol in preparation for a clinical trial on blood-brain-barrier opening (BBBO) by magnetic resonance-guided focused ultrasound (MRgFUS) for chemo-drug delivery to brian tumors. The procedures were approved by the Institutional Animal Care Committee. A trans-human skull porcine model was designed for the preclinical testing. Wide craniotomies were applied on 11 porcine subjects (~15 kg). A partial human skull was positioned over the animal’s brain. A modified clinical MRgFUS brain system (ExAblate 4000, 230 kHz) was used with a 3T MR scanner (Signa MR750, GE Healthcare). The ultrasound beam was steered during sonications over a 3×3 grid at 3 mm spacing. Acoustic power levels from 3 to 20 W were tested. Bolus injections of Definity microbubble at 4 ul/kg were tested for each sonication. Levels of BBB opening, hemorrhage and cavitation signal were measured by MR imaging, histology and cavitation receivers, respectively. A cavitation safety algorithm was developed based on logistic regression of the measurements and tested to minimize risks of hemorrhage. BBBO of approximately 1 cm3 in volume were visualized by Gd-enhanced MR imaging post sonication at ~5 W acoustic powers. Gross examination of histology confirmed Evans blue (bound to macromolecule albumin) extravasation, and H&E staining detected only scattered extravasation of red blood cells. In cases where cavitation signals were above thresholds, sonications were terminated immediately without causing hemorrhage. With a trans-human skull porcine model, this study demonstrated BBBO with the 230 kHz ExAblate system in preparation for a clinical trial.
登录
查看更多内容
影响因子:
19.7
作者:
Hynynen, K;McDannold, N;Jolesz, FA
通讯作者:
Jolesz, FA
影响因子:
11.2
作者:
McDannold N;Arvanitis CD;Vykhodtseva N;Livingstone MS
通讯作者:
Livingstone MS
DOI:
10.1109/tbme.2009.2034533
发表时间:
2010-01
期刊:
IEEE transactions on bio-medical engineering
影响因子:
--
作者:
Choi JJ;Feshitan JA;Baseri B;Wang S;Tung YS;Borden MA;Konofagou EE
通讯作者:
Konofagou EE
影响因子:
2.9
作者:
McDannold, Nathan;Vykhodtseva, Natalia;Hynynen, Kullervo
通讯作者:
Hynynen, Kullervo
影响因子:
158.5
作者:
Elias, W. Jeffrey;Huss, Diane;Wintermark, Max
通讯作者:
Wintermark, Max